Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy

Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy

Blog Article

The novel coronavirus-2019 (COVID-19) has caused a global pandemic of historical proportions, infecting millions of people worldwide.Due to its high mortality rate and a paucity of clinical BENCH data, experimental therapies have been utilized with uncertain success and, unfortunately, Horse Rein Accessories poor outcomes.We describe a gentleman who was treated with experimental therapies and subsequently developed cytomegalovirus colitis and hypovolemic shock.Additionally, this case validates colonoscopy as a mode to rule out concurrent infectious etiologies causing diarrhea in COVID-19-positive patients.